HighPeak Energy reported Q1 2026 results after the bell on May 6 — and the market got two punches at once: an adjusted EPS miss and a surprise $150 million at-the-market equity offering filed the same evening.
The results were unambiguously mixed. Sales of $215.6 million beat consensus by roughly $2 million. But adjusted EPS came in at -$0.02, missing the $0.04 estimate. The ATM offering landed minutes later, signalling the company intends to use the stock as a funding tool near current lows — a combination that rarely sits well with existing holders.
Options traders had already sensed the risk before the numbers landed. The put/call ratio spiked to 3.12 on May 5, more than three standard deviations above its 20-day average of 2.13 — the most defensively skewed reading in months. That surge came in a single session; for the four prior weeks, the PCR had been drifting between 1.88 and 2.60. The overnight jump to 3.12 reflects concentrated demand for downside protection ahead of the print, and the offering news likely validates that positioning.
Short sellers had been building pressure through April. Short interest rose 15% over the past month to 6.6% of the free float, peaking at around 8.6 million shares in mid-April before easing slightly this week. Borrow costs have pulled back — cost to borrow is now running near 6.2%, down from a 30-day high above 9.5% in late March — but availability remains in the tight-to-moderate zone, suggesting the lending market has eased somewhat but is far from loose. The ORTEX short score holds at 81.2, well into elevated territory and broadly unchanged across the past two weeks, meaning the composite picture of short positioning has not materially shifted.
The stock is at $6.79, down 1.9% on the day and off roughly 1.6% on the month. The mean analyst price target on record is $7.88 — fractionally above the current price — though most of that coverage dates back to 2025 and should be treated as indicative rather than current. Peer E&P names had a better week: CHRD gained 6.4% on the week and FANG added 3.1%, underscoring that HPK's underperformance is stock-specific rather than sector-driven. The EV/EBITDA multiple sits near 3.3x — inexpensive by sector standards — but the ATM overhang and a near-term EPS miss give the Street little reason to re-rate upward immediately. The EPS surprise factor score of 91 reflects a strong historical beat record, making this quarter's miss more jarring by contrast.
The ownership structure constrains the float further. HighPeak Energy Management holds 64% of shares. John DeJoria controls another 12%. Publicly traded float is thin, which amplifies both the dilutive impact of the ATM and the sensitivity of the stock to any shift in short positioning. The most recent insider trades on record were three executive sells at $4.74 in December 2025 — now stale by several months — while CEO Jack Hightower's cluster of open-market buys in August–September 2024 came at prices between $15 and $16, a reminder of how far the stock has travelled since then.
What to watch: whether the ATM offering is drawn down aggressively in coming weeks, how management frames capital allocation and production guidance on the earnings call, and whether the PCR normalises or holds at elevated levels as the market digests both the earnings miss and the dilution announcement together.
See the live data behind this article on ORTEX.
Open HPK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
